Tesfa Endalamaw, Munshea Abaineh, Nibret Endalkachew, Mekonnen Daniel, Sinishaw Mulusew Alemneh, Gizaw Solomon Tebeje
Department of Medical Biochemistry, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Health Biotechnology Division, Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia.
Heliyon. 2022 Oct 14;8(10):e11098. doi: 10.1016/j.heliyon.2022.e11098. eCollection 2022 Oct.
Pre-eclampsia (PE) is a metabolic disorder that adversely affects the lives of mother and their infants. Even though, several studies have been conducted on PE, no effective diagnostic and therapeutic agents were developed so far. Hence, this study was designed to evaluate serum uric acid, blood urea and creatinine levels in the prediction of PE.
A hospital-based case-control study was conducted among pregnant women. A simple random sampling technique was applied to select study participants. The socio-demographic and clinical data were collected using an interview-administered questionnaire. Serum samples were used to determine the maternal uric acid, urea and creatinine levels via an automated chemistry analyzer. Independent sample t-test, Pearson correlation test and receiver operating characteristic (ROC) curve analysis were performed to check the association and diagnostic accuracy of variables to PE.
The mean ages (in years) of the case and control groups were 27.98 ± 5.64 and 27.33 ± 4.45, respectively. The mean serum uric acid and blood urea levels were significantly higher in pre-eclamptic women than in normotensive pregnant women (6.27 ± 0.20 vs 4.43 ± 0.15, and 8.50 ± 3.99 vs 5.67 ± 2.19), respectively but the serum creatinine level is non-significantly increased in cases as compared to controls (0.70 ± 0.05 vs 0.50 ± 0.01). The areas under the ROC curve of serum uric acid, creatinine and blood urea levels were 0.785, 0.735 and 0.764 (sensitivity: 69%, 60.7%, 67.9%; specificity: 73.8%, 75%, 71.4%) with the cutoff points of ≥5.25 mg/dL, ≥0.565 mg/dL and ≥6.5 mg/dL, respectively.
In this study, we observed a significantly higher concentration of serum uric acid and blood urea values in pre-eclampsia as compared with normotensive pregnant women. Therefore, this suggested that serum uric acid; blood urea and creatinine values can be associated with PE. Moreover, serum uric acid, blood urea and creatinine levels could be carefully utilized as a diagnostic marker for PE, but their inclusion in routine diagnostic test to PE requires large-scale multi-center prospective studies that corroborate our findings.
子痫前期(PE)是一种代谢紊乱疾病,对母亲及其婴儿的生命产生不利影响。尽管已经针对子痫前期开展了多项研究,但迄今为止尚未开发出有效的诊断和治疗药物。因此,本研究旨在评估血清尿酸、血尿素和肌酐水平在子痫前期预测中的作用。
在孕妇中开展了一项基于医院的病例对照研究。采用简单随机抽样技术选择研究参与者。使用访谈式问卷收集社会人口统计学和临床数据。通过自动化学分析仪使用血清样本测定母体尿酸、尿素和肌酐水平。进行独立样本t检验、Pearson相关检验和受试者工作特征(ROC)曲线分析,以检验各变量与子痫前期的关联及诊断准确性。
病例组和对照组的平均年龄(岁)分别为27.98±5.64和27.33±4.45。子痫前期妇女的平均血清尿酸和血尿素水平显著高于血压正常的孕妇(分别为6.27±0.20 vs 4.43±0.15,以及8.50±3.99 vs 5.67±2.19),但与对照组相比,病例组的血清肌酐水平虽有升高但无统计学意义(0.70±0.05 vs 0.50±0.01)。血清尿酸、肌酐和血尿素水平的ROC曲线下面积分别为0.785、0.735和0.764(敏感性:69%、60.7%、67.9%;特异性:73.8%、75%、71.4%),截断点分别为≥5.25mg/dL、≥0.565mg/dL和≥6.5mg/dL。
在本研究中,我们观察到子痫前期患者的血清尿酸和血尿素浓度显著高于血压正常的孕妇。因此,这表明血清尿酸、血尿素和肌酐值可能与子痫前期有关。此外,血清尿酸、血尿素和肌酐水平可谨慎用作子痫前期的诊断标志物,但将它们纳入子痫前期的常规诊断测试需要大规模多中心前瞻性研究来证实我们的发现。